Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Enfusion, Inc. ENFN
$8.10
-$0.04 (-0.49%)
На 18:05, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
678988251.00000000
-
week52high
16.76
-
week52low
7.80
-
Revenue
150349000
-
P/E TTM
-56
-
Beta
0.00000000
-
EPS
-0.10000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 12:30
Описание компании
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Morgan Stanley | Equal-Weight | Equal-Weight | 10 авг 2022 г. |
| Goldman Sachs | Neutral | Neutral | 14 июл 2022 г. |
| Piper Sandler | Overweight | Overweight | 06 июл 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 13 мая 2022 г. |
| Credit Suisse | Neutral | Neutral | 13 мая 2022 г. |
| B of A Securities | Neutral | Buy | 03 окт 2022 г. |
| B of A Securities | Underperform | Neutral | 04 янв 2023 г. |
| Morgan Stanley | Overweight | Equal-Weight | 03 янв 2023 г. |
| Goldman Sachs | Neutral | Neutral | 26 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Bachert Steven M. | D | 190332 | 9632 | 25 янв 2023 г. |
| Bachert Steven M. | A | 199964 | 35739 | 25 янв 2023 г. |
| Bastone Bronwen | D | 163421 | 218 | 25 янв 2023 г. |
| Bastone Bronwen | A | 163639 | 638 | 25 янв 2023 г. |
| LEIBOWITZ LAWRENCE E | A | 64839 | 7238 | 25 янв 2023 г. |
| Groman Dan | D | 93733 | 9219 | 25 янв 2023 г. |
| Groman Dan | A | 102952 | 21976 | 25 янв 2023 г. |
| Skillman Lorelei M. | D | 46513 | 184 | 25 янв 2023 г. |
| Skillman Lorelei M. | A | 46697 | 483 | 25 янв 2023 г. |
| Skillman Lorelei M. | D | 46214 | 3382 | 23 янв 2023 г. |
Новостная лента
5 Stocks to Pop Surprise Returns From Secret Santa
Zacks Investment Research
22 дек 2022 г. в 09:48
Adicet Bio (ACET), Enfusion (ENFN), Dillard's (DDS), First BanCorp. (FBP) and Hillenbrand (HI) could bring gifts of surprise returns from Secret Santa.
Enfusion: Cloud-Native Solution To Disrupt Legacy Providers
Seeking Alpha
30 ноя 2022 г. в 23:37
Several tailwinds in the investment industry will support ENFN's growth. ENFN has a better solution that is evolving.
Enfusion, Inc. (ENFN) Q3 2022 Earnings Call Transcript
Seeking Alpha
12 ноя 2022 г. в 05:18
Enfusion, Inc. (NYSE:ENFN ) Q3 2022 Earnings Conference Call November 10, 2022 5:00 PM ET Company Participants Ignatius Njoku – Head-Investor Relations Oleg Movchan – Interim Chief Executive Officer Steve Dorton – Chief Financial Officer Conference Call Participants Kevin McVeigh – Credit Suisse James Faucette – Morgan Stanley Matthew Kikkert – Stifel Natalie Howe – Bank of America Dylan Becker – William Blair Operator Good afternoon, ladies and gentlemen. Thank you for standing by.
Enfusion, Inc. (ENFN) CEO Thomas Kim on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha
13 авг 2022 г. в 15:33
Enfusion, Inc. (NYSE:ENFN ) Q2 2022 Results Conference Call August 9, 2022 5:00 PM ET Company Participants Ignatius Njoku - Head, IR Thomas Kim - CEO Steve Dorton - CFO Conference Call Participants Matthew Kicker - Stifel Tanaka Mehta - Bank of America James Faucette - Morgan Stanley Faith Brunner - William Blair Operator Good afternoon, ladies and gentlemen. Thank you for standing by.
Enfusion Announces Second Quarter 2022 Earnings Release Date
Business Wire
22 июл 2022 г. в 09:00
NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-native software-as-a-service (“SaaS”) solutions for investment managers, today announced that it will report its second quarter fiscal year 2022 financial results after the U.S. financial markets close on Tuesday, August 9, 2022. Webcast and Conference Call Details In conjunction with this announcement, Enfusion will host a conference call at 2:00 PM (PT) / 5:00 PM (ET) on Tuesd